These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15031859)

  • 1. Chronic allograft nephropathy.
    Pietrzyk M; Hoffmann U; Krämer BK
    N Engl J Med; 2004 Mar; 350(12):1254-6; author reply 1254-6. PubMed ID: 15031859
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic allograft nephropathy.
    Ponticelli C
    N Engl J Med; 2004 Mar; 350(12):1254-6; author reply 1254-6. PubMed ID: 15028831
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
    Wali RK; Weir MR
    Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
    Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
    Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm.
    Gaston RS
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):2029-34. PubMed ID: 19850771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic allograft nephropathy--clinical guidance for early detection and early intervention strategies.
    Serón D; Arns W; Chapman JR
    Nephrol Dial Transplant; 2008 Aug; 23(8):2467-73. PubMed ID: 18385386
    [No Abstract]   [Full Text] [Related]  

  • 9. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era.
    Okamoto M; Akioka K; Ushigome H; Higuchi A; Nobori S; Ogino S; Uryuhara K; Kaihara S; Hatta T; Urasaki K; Yoshimura N
    Clin Transplant; 2006; 20 Suppl 15():16-9. PubMed ID: 16848870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic allograft nephropathy.
    Colvin RB
    N Engl J Med; 2003 Dec; 349(24):2288-90. PubMed ID: 14668453
    [No Abstract]   [Full Text] [Related]  

  • 11. The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.
    Coates PT;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S85-7. PubMed ID: 17316286
    [No Abstract]   [Full Text] [Related]  

  • 12. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
    Goldfarb DA
    J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
    [No Abstract]   [Full Text] [Related]  

  • 13. New insights in chronic allograft rejection.
    Paul LC
    Curr Opin Urol; 2002 Mar; 12(2):89-93. PubMed ID: 11859253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic rejection and chronic allograft nephropathy].
    Sugiyama S
    Nihon Jinzo Gakkai Shi; 2004 Oct; 46(7):667-75. PubMed ID: 15570894
    [No Abstract]   [Full Text] [Related]  

  • 15. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
    Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
    Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM; DeMattos A; Meyer MM; Andoh T; Barry JM
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract]   [Full Text] [Related]  

  • 19. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.